ORF launches biorisk-free growth factor range

By Simon Pitman

- Last updated on GMT

Related tags: Anti-aging skin care, Marketing

Iceland-based ORF Genetics says it has launched its next generation
of growth factors, targeting anti-aging products for the
cosmeceuticals category.

Called ISOKine, the range has been produced using the company's patented Orfeus plant-based expression platform, which is claimed to help ensure the purity, safety and bioactivity of the products. The range has been designed as an alternative to current growth factor offerings on the market that are based on animal or bacteria-derived platforms. Plant-derived growth factor​ Because its growth factor is plant-derived this means that, as well as having a lower risk of toxins or contaminants, it is also a more environmentally friendly and less costly option, the company claims. The technology used to develop the new range means that it is guaranteed to be endotoxin-free - a key challenge that cosmeceutical players have struggled to overcome in the past. But as well as the safety issue, the company claims it can also be competitive on price because of enhanced production techniques. High development price means up-market​ The intensive research and development and processing that goes into growth factors invariably means a high price, which invariably sees the ingredient being incorporated into some of the most expensive anti-aging skin care products on the market. However, the company says that the scalability of its production system means that it will be able to tackle large-scale and bulk quantities of ISOkine at 'competitive prices'. Increasingly growth factors are being incorporated into technically advanced anti-aging formulations that are often sold in the cosmeceuticals category, and the company says the launch of its new range is in response to growing demand. Small but growing anti-aging niche​ A small but growing number of anti-aging skin care products that incorporate the technology are currently on the market, combining other high-tech ingredients such as retinol and peptides. Dr. Bjorn Orvar, ORF Genetics CEO, says that the recent In-Cosmetics event in Amsterdam was chosen as the launching pad for the range in Europe and that the response from the industry was 'fantastic'. Further to this, the company says it will use the Supplier's Day show, held in New Jersey, 13-14 May, as the launching pad for the new range on the North Americain market.

Related topics: Formulation & Science, Skin Care

Related news

Related products

show more

TRI-K’s New Vegan Collagen - CollaPlant Z NPNF®

TRI-K’s New Vegan Collagen - CollaPlant Z NPNF®

TRI-K Industries Inc. | 07-Aug-2020 | Data Sheet

CollaPlant Z NPNF® has undergone extensive in-vivo clinical studies and sensory tests that show immediate and long-term increased skin moisturization,...

Multifunctionals for modern product protection

Multifunctionals for modern product protection

Symrise | 15-Jul-2020 | Technical / White Paper

The ‘clean’ movement is more and more of interest to consumers looking for enjoyable but responsible experience. Multifunctionals have a key role to play...

Related suppliers

Follow us


View more